Brief: Osteopore Receives Hainan FDA Approval For Orthopaedic Custom Medical Devices
26/05/2026 02:15
May 26 (Reuters) - Osteopore Ltd OSX.AX: RECEIVES HAINAN FDA APPROVAL FOR ORTHOPAEDIC CUSTOM MEDICAL DEVICES Further company coverage: OSX.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Osteopore
See all newsBrief: Osteopore Secures Market Access In Thailand For Full Range Of Orthopaedic Products
Brief: Osteopore Strikes Orthopaedic Deal For 5 Middle East Countries
Brief: Osteopore Achieves Market Access To Saudi Arabia For Craniofacial Products
Brief: Osteopore Launches Clinical Study For Paranasal Augmentation In Patients With Unilateral Cleft Lip
Australia's Osteopore advances on regulatory win in China's Hainan